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ABSTRACT
Extracellular vesicles (EVs) are carriers of different biomacromolecules that 
participate in cellular signaling and disease pathogenesis. Although it has been shown 
that EVs can play an active role in cellular communication and different stages of 
cancer progression, the role of EVs in oral squamous cell carcinoma (OSCC) cancer 
pathogenesis, especially in the crosstalk of cancer cells with immune cells is unknown. 
Here, we present a detailed analysis of findings regarding the profile of EVs in OSCC 
and the role of EVs and associated miRNAs in the crosstalk of malignant cells with 
monocytes. We demonstrate that EVs are detectable in significantly higher quantities 
in the plasma of patients with OSCC. Oncogenic miRNAs (such as miR-21, miR-27) 
were detectable in high quantities in the circulating EVs and plasma of patients with 
OSCC. EVs isolated from the circulation of OSCC patients and OSCC cell lines showed 
comparable miRNA signature, indicating the tumor origin of EVs in the circulation of 
patients with OSCC. Danger signals such as LPS and ethanol increased the production 
of EVs. EVs were taken up by monocytes after co-culture. Mechanistically, uptake of 
EVs derived from oral cancer cells by monocytes caused activation of the inflammatory 
pathway, NF-κB activation, and establishment of a pro-inflammatory and pro-
tumorigenic milieu marked by increased levels of IL-6, CCL2, PEG2 and MMP9 levels. 
Series of experiments involving the introduction of exogenous oncogenic miR-21 
mimic induced a similar pro-inflammatory and pro-tumorigenic profile in monocytes. 
Inhibiting miR-21 function in monocytes attenuated the pro-inflammatory phenotype 
of monocytes after EV challenge. These results indicate the role of EV-associated miR-
21 in modulating the immune response in monocytes.
www.oncotarget.com                               Oncotarget, 2018, Vol. 9, (No. 78), pp: 34838-34854
INTRODUCTION
Oral cancer is a global health problem that 
demonstrates a challenge to the health care system [1]. 
Oral squamous cell carcinoma (OSCC) accounts for more 
than 90% of oral cancers [1, 2]. Several risk factors for 
OSCC such as smoking, alcohol consumption, smokeless 
tobacco use, and infection with human papillomavirus have 
been reported [3–5]. Despite the advances in the cancer 
treatment the 5-year survival of oral cancer is around 50% 
in various stages of the disease [6]. However, more than 
60% of patients present with stage III or IV of the disease 
at the time of diagnosis which leads to even less survival 
rate. Therefore, a better understanding of the initial events 
in OSCC is needed to improve early detection and disease 
intervention. 
Extracellular vesicles (EVs), membrane vesicles of 
cell origin, are emerging as key players in intercellular 
communication between cells and their microenvironment 
through horizontal transfer of cargo which contains 
proteins, DNAs, messenger RNAs, and microRNAs 
[7–10]. Extracellular vesicle is a collective 
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term for exosomes and microvesicles. 
Exosomes are the smallest (30–100 nm) 
subpopulation of EVs and are originated from 
multivesicular bodies. Microvesicles (also called shedding 
vesicles, shedding microvesicles, or microparticles) are 
approximately 100–1000 nm in diameter and originate 
from the outward budding of the plasma membrane [11, 
12]. EVs have been isolated from almost all cell types and 
different bio-fluids including blood, urine, cerebrospinal 
fluid, and saliva [11]. They have been implicated in critical 
cellular processes such as growth and development, 
cell-to-cell communication, immunomodulation, blood 
coagulation, and various stages of tumorigenesis [13–15]. 
Several groups have demonstrated that presence of 
pathological states such as oxidative stress, transformation, 
apoptosis, and alcohol-induced cell injury trigger cells to 
increase their EV release rate, simultaneously altering their 
composition to reflect the altered state of the cellular origin 
[16–18]. Upon secretion, EVs can be taken up by other cells 
and modulate the recipient cell function through horizontal 
transfer of biomacromolecules or activation of surface 
receptors [19, 20]. Recently, the role of EVs in various 
phases of cancer initiation, cancer progression, and metastasis 
formation was shown in different cancers such as pancreatic 
cancer, colon cancer, lung cancer, malignant melanoma, and 
breast cancer [21–25]. Studies have shown the role of EVs in 
oral cancer [26, 27]. However, immune response mediated by 
EVs originated from oral cancer cells is not known. 
Evidence regarding molecular and cellular 
mechanisms underlying cancer development indicates 
that immune changes occur during cancer development 
and progression. Alcohol is considered one of the risk 
factors for oral squamous cell carcinoma (OSCC) and 
associated with poor prognosis which is also a modulator 
of innate immunity [28]. Here, we present a detailed 
analysis of the role of EVs and associated miRNAs in 
cellular crosstalk in OSCC. We demonstrate that EVs are 
detectable in significantly higher quantity in circulations 
of patients with OSCC and the majority of extracellular 
RNA are packed in the EVs. Oncogenic miRNAs were 
detectable in high quantity in the circulating EVs and 
plasma of patients with OSCC. We also performed a 
series of experiments to characterize the EVs shed by oral 
cancer cells in resting state and in response to the alcohol 
challenge. We found that alcohol challenge increases EV 
production in a dose-dependent manner and subset of 
oncogenic miRNAs are specifically enriched in the EVs 
released form the cancer cells. Mechanistically, uptake of 
EVs derived from oral cancer cells by monocytes causes 
activation of the NF-κB pathway and establishment of 
the pro-inflammatory milieu. These findings suggest that 
EV-associated miRNAs may be a marker, as well as a 
functional component, of cancer cells and immune cells 
interactions. In summary, our study describes a previously 
unknown pro-inflammatory circuit through which OSCC-
derived EVs can induce the formation of pro-inflammatory 
phenotype in monocytes. 
RESULTS
Extracellular vesicles are increased in patients 
with OSCC and carry oncogenic miRNAs
We examined the number and composition of EVs 
in patients with OSCC and gender-matched controls. The 
baseline characteristic of human subjects is presented 
in Supplementary Table 1. We enumerated extracellular 
vesicles in the plasma of patients with OSCC, using a 
nanoparticle tracking analysis (NTA) system. We found an 
increased number of EVs in plasma of patients with OSCC 
compared to the controls (up to 3.2 times) (p < 0.001) 
(Figure 1A). The size of extracellular vesicles was 
significantly larger in patients with OSCC compared to 
healthy controls with the average of 389 nm in OSCC and 
178 nm in controls (p < 0.05). The data indicate that the 
extracellular vesicles were mostly in the range of a larger 
group of extracellular vesicles called microvesicles or 
microparticles (Figure 1B). Circulating EVs carried small 
RNA cargo as represented in bioanalyzer results obtained 
by small RNA chip (Figure 1C). miRNA profile of 
circulating miRNA revealed increased levels of oncogenic-
related miRNAs including miR-21, miR-27a, miR-27b, 
and miR-155 in the plasma of patients of patients with 
OSCC compared to the controls with the average fold 
changes of 5.16, 4.1, 12.80, and 4.2 respectively (p < 0.05) 
(Figure 1D–1G). In contrast, miR-16 showed no change 
in plasma of patients with OSCC compared to the controls 
(p > 0.05) (Figure 1H). Profiling of EVs isolated from 
plasma of patients with OSCC showed that miR-21, 
miR-27b, and miR-27a were specifically enriched in EVs 
compared to the non-EV fraction (Figure 1I, 1J). 
Oral cancer cell line produces an increasing 
number of extracellular vesicles after stimulation 
with danger signals
Since we found an increased number of EVs in 
patients with OSCC, we postulated that the origin of the 
EVs were OSCC cells. We further study the CAL27 cell 
line (ATCC® CRL2095™), a human oral squamous cell 
carcinoma cell line, to characterize the content and function 
of EVs. We found that OSCC cells shed a considerable 
amount of EVs and those EVs were increased after 
stimulation with danger signals including ethanol and LPS. 
In a series of experiments, we challenged OSCC 
cells with a different dose of LPS and ethanol to identify 
the effect of ethanol and LPS stimulation on the EV 
production and miRNA signature. Administration of 
10 ng/ml and 100 ng/ml LPS significantly increased a total 
number of extracellular vesicles in CAL27 cells. Similarly, 
administration of 25 mM, 50 mM, 100 mM ethanol for 
24 h, 48 h, and 72 h which are clinical equivalent of mild 
ethanol exposure, moderate ethanol exposure, and severe 
ethanol exposure [29], showed a significant increase in 
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the number of extracellular vesicles (Figure 2A–2D). 
Interestingly, administration of both LPS and ethanol 
challenges induced more increase in the larger subset of 
extracellular vesicles (microvesicles) compared to the 
smaller subpopulation (exosomes) and mean diameter 
of extracellular vesicles was increased significantly after 
24 h challenge with 25 mM ethanol and 10 ng/ml LPS 
(Figure 2E–2G). EVs released after alcohol challenge 
(25 mM) showed the increased average size of 348 nm 
compared to the control cells with an average size of 
162nm. Characterization of extracellular vesicles from 
CAL 27 cells with western blot revealed the presence 
of EV marker CD63 (Supplementary Figure 1). RNA 
encapsulated in EVs was protected against RNases in both 
EVs isolated from plasma and culture media of CAL27 
cells (Supplementary Figure 2). CAL27 cells produce 
extracellular vesicles as shown in the scanning electron 
microscopy image (left image). Higher magnification 
reveals EVs ranging from 50–500 nm in diameter 
(Figure 2H). We then conducted bioanalyzer capillary 
electrophoresis on all EV-associated RNA to identify their 
size distributions. Small species ranging in size from <150 
nt were most prevalent in all examined electrophoretic 
profiles, although signatures of longer transcripts were 
also present (Figure 2I).
EVs derived from oral squamous cell carcinoma 
cells are enriched in oncogenic miRNAs
Next, we hypothesized that EVs derived from oral 
squamous cell carcinoma contain oncogenic miRNAs. 
To identify deregulated miRNAs in cell line and EVs in 
the absence and presence of ethanol, we challenged cells 
with ethanol 25 mM for 24 h and miRNA analysis was 
carried out using the Firefly miRNA multiplex assay 
for oncology panel. Interestingly, the miRNA profile of 
EVs derived from ethanol challenged cells was mostly 
similar to the EVs isolated from non-challenged cells 
with the exception of 5 miRNAs: miR-378a-3p, miR-
130a-3p, miR-181a-5p, miR -205-5p, and miR-122-5p 
(Table 1). This data indicates that the effect of ethanol 
on the cancer cells is most effective on the magnitude of 
production of EVs and a subset of miRNAs packaging. 
miRNAs were selectively enriched into the EVs, and 
the profile of miRNA was different in EVs and the cells 
(Figure 3A, 3B). The packaging of cellular miRNAs into 
Figure 1: Number of EVs and oncogenic miRNAs are increased in the plasma of patients with OSCC. (A) Total number 
of EVs in the plasma of patients with OSCC and matched controls were measured by a Nanoparticle Tracking analysis (Nanosight) 
(n = 34). Each measurement was done in triplicate. (B) The average size of exosomes was measured by Nanoparticle Tracking analysis 
(NTA) in control and OSCC patients. (C) The graph is representative of small RNA of EVs isolated from plasma of patients with OSCC 
as analyzed by BioAnalyzer. (D–H) Signature of plasma miRNAs in patients with OSCC and controls was assessed with a TaqMan 
miRNA qPCR assay for quantification of miR-21, miR-155, miR-27a, miR-27b, miR-16. miR-Cel-39 was used as exogenous normalizer. 
(I, J) Expression levels of miR-27a, miR-27b, and miR-21 was identified in EV fraction and non-EV fraction of plasma starting from 
same amount of plasma (100 µl) with a TaqMan miRNA qPCR assay (n = 10 control, 10 OSCC patients). After isolation of EVs RNase A 
treatment at final concentration of 5 µg/mL for 30 min was done. (*indicates p < 0.05 versus control).
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the EVs was specific, and some of the top miRNAs which 
differentially expressed between cells and EVs were: miR-
7d-5p, miR-130a-3p, miR-181a-5p, miR-107, miR-21-5p, 
miR-103a-3p, miR-22-3p, miR-20a-5p (Table 1). 
Interestingly, miR-21, miR-27a, miR-205, and 
miR-17a showed very high signals in both cells and EVs 
indicating an abundance of these miRNAs in both cancer 
cells and released EVs (Figure 3C–3F). 
EVs miRNA signature targets multiple cancer 
and immune system associated pathways
Massive miRNA-gene interaction is present 
in cellular pathways. For example, KEGG pathway 
enrichment analysis of miRNA targets has revealed tens of 
thousands of miRNA-gene interactions [30]. Specifically, 
miR-21 shows the highest regulatory activity of biological 
pathways by targeting over 1400 genes. miRNAs which 
showed significant enrichment in EVs (miR-22-3p, miR-
130a-3p, miR-20a-5p, miR-21-5p, miR-195-5p, miR27a-
3p, miR-19a-3p) were entered to the network-based analysis 
(Figure 4A). We identified 40 KEGG pathways potentially 
regulated by combined miRNA signature. Significant 
enriched pathways were “Pathways in cancer”, “P53 
signaling pathway”, “mTOR signaling pathway”, “Jak-
STAT signaling pathways”, “Cell cycle”, and “Chemokine 
Signaling Pathway”. We identified 132 Reactome pathways 
as potential pathways regulated by combined miRNA 
signature including “Oncogene-induced senescence”, 
“Signaling by TGF-beta receptor complex”, “Cellular 
response to stress”, “Toll-like receptor 7/8 cascade”, 
“Immune system,” and “Innate immune system.” The 
gene set enrichment analysis results showed this miRNA 
network regulates multiple pathways involved in cancer 
and innate immune function. Top significant pathways are 
shown in Figure 4B and 4C. The complete set of pathways 
obtained from gene set enrichment analysis are included 
as Supplementary Table 2 and Supplementary Table 3. 
Figure 2: Ethanol treatment increases total number of EVs in a dose- and time-dependent manner in CAL27 cells. 
CAL27 cells were cultured, and numbers of EVs, exosomes (size <150 nm), and MVs (size >150 nm) were quantified in cell-free 
supernatant by NanoSight. (A) CAL27 cells were exposed to various dose of ethanol (25 mM, 50 mM, 100 mM), LPS (10 ng, 100 ng) or 
left untreated for 24 h, and the frequency of vesicles was determined. (B) CAL27 cells were exposed to various dose of ethanol (25 mM, 
50 mM, 100 mM), LPS (10 ng, 100 ng), or left untreated for 48 h, and the frequency of vesicles was determined. (C) CAL27 cells were 
exposed to various dose of ethanol (25 mM, 50 mM, 100 mM), LPS (10 ng, 100 ng), or left untreated for 72 h, and the frequency of vesicles 
was determined. (D) Kinetic of EV production after challenge with 50 mM ethanol was determined at each condition by enumerating the 
number of EVs in the cell supernatants. (E) Size distribution of EVs produced by CAL27 cells in 24 h in the unchallenged condition. 
(F) Size distribution of EVs produced by CAL27 cells challenged by 25 mM ethanol in 24 h. (G) Size distribution of EVs produced 
by CAL27 cells challenged by 10 ng LPS in 24 h. Nanosight device was calibrated with 100 nm polystyrene beads before each set of 
measurements. All measurements were done in triplicate from 6 independent samples in each group. (H) Scanning electron microscopy 
image of untreated CAL27 cells are shown (×3000 magnification). The blown-up image of the selected region (×7500 magnification) 
in the cancer cells shows the shedding of EVs on the surface of the cells. (I) EVs originated from CAL27 cells carry small noncoding 
RNAs in size range of miRNAs. Figure is the representation of EV-encapsulated small RNA profile obtained from 4 independent sample 
preparations. (*indicates p < 0.05 versus control).
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Table 1: List of differentially expressed miRNAs in OSCC cells and EVs
Fold adjusted p-value raw p-value
Alcohol versus control
hsa-mir-146a-5p 1.47 0.525 0.011
hsa-mir-27a-3p 1.32 0.965 0.050
Control EVs versus Alcohol EVs
hsa-mir-378a-3p 1.27 0.463 0.009
hsa-mir-130a-3p 0.78 0.758 0.021
hsa-mir-181a-5p 1.81 0.928 0.039
hsa-mir-205-5p 1.34 0.929 0.039
hsa-mir-122-5p 0.20 0.958 0.047
hsa-mir-146a-5p 1.60 0.964 0.049
hsa-mir-181b-5p5p 1.95 0.964 0.049
EVs versus cells
hsa-mir-378a-3p 1.27 0.463 0.009
hsa-mir-130a-3p 0.78 0.758 0.021
hsa-mir-181a-5p 1.81 0.928 0.039
hsa-let-7d-5p 13.33 0.001 0.000
hsa-mir-107 7.53 0.002 0.000
hsa-mir-200b-3p 2.96 0.010 0.000
hsa-mir-103a-3p 7.08 0.010 0.000
hsa-mir-130a-3p 0.52 0.013 0.000
hsa-mir-22-3p 0.69 0.014 0.000
hsa-mir-20a-5p 0.74 0.042 0.001
hsa-mir-148a-3p 0.76 0.043 0.001
hsa-mir-26a-5p 10.05 0.054 0.001
hsa-let-7g-5p 8.58 0.057 0.001
hsa-mir-148b-3p 0.75 0.100 0.002
hsa-mir-15b-5p 1.78 0.150 0.002
hsa-let-7i-5p 4.14 0.171 0.003
hsa-mir-181a-5p 3.90 0.173 0.003
hsa-mir-18a-5p 1.90 0.253 0.004
hsa-mir-106b-5p 1.62 0.337 0.006
hsa-mir-181b-5p 2.24 0.515 0.011
hsa-mir-155-5p 4.03 0.519 0.011
hsa-mir-10b-5p 2.34 0.643 0.015
hsa-mir-34a-5p 2.08 0.728 0.020
hsa-mir-21-5p 0.68 0.796 0.024
hsa-mir-29b-3p 2.03 0.825 0.026
hsa-mir-151a-3p 1.65 0.878 0.031
hsa-mir-222-3p 0.82 0.939 0.041
hsa-mir-19a-3p 0.50 0.943 0.042
hsa-mir-192-5p 2.84 0.963 0.049
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Analysis of miRNA-small molecule interactions revealed 
that the EV miRNA signature interacts with various drugs 
which routinely used in cancer therapy including 5-aza-2′-
deoxycytidine, 5-fluorouracil, Trichostatin A, among others 
(Supplementary Figure 3). These in silico analyses revealed 
the possible role of this miRNA network in cancer (p53/
TGFβ/SMAD/apoptosis pathways) and immune function. 
In accordance with in silico analyses, miR-21 is shown to 
modulate various genes involved in p53/TGFβ/apoptotic/
SMAD pathways [31] and in immunity [32]. Consistent 
with patient data, miR-21 showed the highest uniform 
signal intensity across different groups in both cells and 
Figure 3: Characterization of miRNA cargos of EVs secreted by OSCC cells (CAL27). (A) Heat map of differentially 
expressed EV-associated miRNAs in oral squamous cell carcinoma cell lines (CAL27) using Firefly BioWorks miRNA assay normalized 
to the geometric mean of most stable miRNAs. (B) Volcano plot of significant relative to the fold change expression of miRNAs for cell 
versus EVs. (C–F) Normalized signal intensity of miR-21, miR-27a, miR-205, and miR-17 in CAL27 cell and EVs (*indicates p < 0.05 
versus control).
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EVs. This data confirmed by qPCR and consistently miR-
21 showed lower Ct values in both CAL27 cells, and EVs 
derived from those cells (Ct value: 24 in 10 ng cDNA). 
miR-21 is an oncogenic miRNA which plays a key role 
in resisting programmed cell death, targeting numerous 
tumor suppressor genes associated with proliferation, 
apoptosis, and invasion [33, 34]. Overexpression and role 
of miR-21 as one of the essential oncomiRs in head and 
neck cancer has been underlined [35–38]. We hypothesized 
that EVs released by OSCC and increased production of 
EVs due to the ethanol challenge plays a role in tumor 
microenvironment modulation and increased miR-21 has a 
role in modulating monocyte functions. 
EVs derived from cancer cells are taken up by 
monocytes and activate NF-κB pathway
We further characterized the content of EVs derived 
from CAL27 cells with and without ethanol stimulation. 
To mimic the biological concentration and phenomena, we 
normalized the EVs RNA based on the number of parental 
cells. This normalization enabled us to compare more 
relevant biological phenomenon after ethanol challenge 
which accompanied by an increase in the number of EVs. 
EVs derived from CAL27 cells at normal condition, and 
under ethanol challenge contained the high signal of miR-21 
(24 Ct value for normal condition and 22 Ct value after 
ethanol challenge) (Figure 5A). Those EVs were also 
highest in IL-6 protein content but no change in the levels 
of MCP1 and IL-1b protein content (Figure 5B–5D). To 
check whether the changes in the miR-21 cargo after 
ethanol challenge is specific to EVs derived from CAL27 
cells, we used THP1 cells as a control cell line. Level of 
miR-21 and IL-6 were not significantly altered in THP1 
cells derived EVs after ethanol challenge (Figure 5E, 5F). 
These findings indicate selective increase and sorting of 
cargos into the EVs. Further, EVs derived from CAL27 
cells were labeled with PKH67 green fluorescent and 
were taken up by THP1 monocytes after 2 h co-culture 
(Figure 5G). miR-21 was increased in the THP1 monocytes 
after 3 h co-culture of EVs and THP1 cells (Figure 5H). 
Both control EVs and ethanol-induced EVs transferred 
miR-21 to THP1 human monocytes, with an increase in 
miR-21-fold expression in the THP1 monocytes which was 
expected since more EVs was present in the supernatant 
of alcohol-treated cells with the same number of parental 
cells (Figure 5H). We ruled out the endogenous source 
of miR-21 by performing primary transcript containing 
miR-21 (pri-miRNA-21) qPCR in the cells. No change 
in pri-miRNA-21 was found after 3 h of co-culture of 
EVs derived from OSCC in the monocytes (Figure 5I). 
Interestingly, pri-miRNA-21 was significantly increased 
18 h after co-culture of EVs derived from OSCC in the 
monocytes, indicating later induction of miR-21 after 
internalization of EVs and de novo synthesis of miR-21 
at later time points (Figure 5J). To further confirm that the 
Figure 4: Network analysis and gene set enrichment analysis of miRNAs enriched in OSCC derived EVs. (A) Target 
interaction network for miRNA enriched in the OSCC EVs. Schematic was obtained from miRNet.ca. (B) Selected KEGG pathway 
analysis significant results combining gene targets of selectively enriched miRNAs in OSCC EVs were shown. (C) Selected Reactome 
pathway analysis significant results combining gene targets of selectively enriched miRNAs in OSCC EVs were shown.
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uptake of EVs was an active process and leads to increase 
in miR-21 was related to the endocytosis pathways, we 
used Cytochalasin D. Cytochalasin D is a metabolite known 
to depolymerize the actin filament network resulting in 
inhibition of endocytic pathways and EVs uptake in a dose-
dependent manner [39, 40]. Cytochalasin D treatment leads 
to a dose-dependent decrease in miR-21 level (Figure 5K), 
indicating that the uptake of EVs containing miR-21 is 
an active process and involves endocytosis. To determine 
the function of EVs in recipient THP1 monocytes we 
performed an electrophoretic mobility shift assay (EMSA) 
specific to NF-κB consensus sequences. The results showed 
activation of NF-κB (p65/50 heterodimers) in THP1 
monocytes, 4 hours after treatment with EVs derived from 
CAL27 cells (Figure 5L). Consistent with other studies, 
LPS treatment resulted in NF-κB activation in our system 
(Figure 5L). These results suggest a biological role of EVs 
in recipient THP1 monocytes. 
EVs derived from cancer cells reprogram 
monocytes via NF-κB pathway
It has been evidenced that EVs have the ability to 
modify tumor microenvironment and circulating immune 
cells [21, 22]. Our results suggest activation of NF-
κB by EVs in recipient THP1 monocytes, therefore, we 
postulated that EVs derived from OSCC could modulate 
tumor-associated monocyte/macrophages activity and 
may influence cancer biology. We further characterized 
the effect of EVs derived from CAL 27 cells on cytokine 
and chemokine production profile of THP1 cells. 
Monocyte chemoattractant protein-1 (MCP-1) is one 
of the derivers of tumor progression which molds the 
tumor microenvironment and promote the pro-oncogenic 
environment [41, 42]. 12 hours after co-culture of EVs 
derived from CAL27 cells the MCP1 mRNA level was 
increased significantly in recipient THP1 monocytes 
(Figure 6A). Consistently, MCP1 protein level was 
significantly increased 24 h and 48 h after co-culture of 
EVs with THP1 monocytes (Figure 6B, 6C). EVs derived 
from alcohol treated CAL27 cells further augmented the 
levels of MCP1 (mRNA and protein) in recipient THP1 
monocytes (Figure 6A–6C). Level of pro-tumorigenic and 
pro-metastasis MMP9 protein, COX2 mRNA levels, PEG2 
mRNA levels, and VEGF mRNA levels were increased 
significantly 24 h after co-culture of EVs with THP1 cells 
(Figure 6D–6G). We also found increased protein levels 
of PGE2 24 h after coculture with EVs (Figure 6H). 
Moreover, IL-6 protein levels were increased 24 h and 48 h 
after co-culture with EVs (Figure 6I, 6J). Enhanced levels 
in COX2 (Figure 6E), VGEF (Figure 6F), and IL-6 (Figure 
6I, 6J) were found in THP1 monocytes after co-culture 
with EVs derived from alcohol treated CAL27 cells. 
These data suggest first EVs derived from CAL cells alone 
can reprogram THP monocytes via modulating NF-kB 
pathway and second, alcohol treatment further enhances 
these effects. Collectively, these data provide the evidence 
of in part modulating immune function to establish a pro-
inflammatory milieu by miR-21. 
To further delineate that the observed NF-κB 
activation was atleast dependent on miR-21 transfer, 
we transfected THP monocytes with miR-21 or control 
mimic and found the similar observation what was 
observed with EV treatment (Figure 7A). Importantly, 
miR-21 overexpression alone caused the NF-κB activation 
(Figure 7A). Consistently, protein levels of IL-6, and 
PGE2, and COX2 mRNA were increased 24 hours after 
introduction of miR-21, consistent with our findings of 
the role of miRNA in the activation of pro-inflammatory 
phenotype in monocytes (Figure 7B–7D). To further test 
the mechanistic role of miRNA-21 in the induction of pro-
inflammatory phenotype loss of function experiment was 
performed by electroporation of miR-21 inhibitor (Figure 
7E). After challenging THP1 monocytes with EVs derived 
from OSCC cells we found significant attenuated level of 
IL-6 protein (Figure 7F) and PGE2 mRNA (Figure 7G) in 
cells after the introduction of miR-21 inhibitor compared 
to miR-21 control inhibitor treated cells. These results 
confirm the mechanistic role of miRNA-21 in part in the 
induction of pro-inflammatory milieu in monocytes.
These results indicate the fact that high content of 
miR-21 in EVs, at least partially, explain the activation 
of NF-κB and observed pro-inflammatory profile. The 
amount of miRNA mimic that was incorporated into the 
cells was comparable to the amount of miR-21 presents 
in EVs isolated from 100 µl of the blood of patients with 
OSCC. 
DISCUSSION
Extracellular vesicles (EVs) are historically 
considered to be membrane-derived cellular debris with 
no biological or clinical significance produced during cell 
death. However, the evidence is amassing that EVs can 
exert multiple physiological and pathological functions 
as an essential mediator of intercellular communications 
[7, 20, 43]. The term ‘EVs’ collectively refers to a 
heterogeneous vesicular population spanning 50 to 10,000 
nm in size. Distinct subpopulations include exosomes, 
microvesicles/microparticles, and apoptotic bodies, 
although the terms not associated with cell death have 
been used interchangeably in the past [44]. These EVs 
are secreted from almost all cell types into the aqueous 
extracellular microenvironment and represent a snapshot 
of the cell status at the time of release, as defined by their 
components [7, 8]. Beyond size, which is itself inadequate 
[45], morphological characteristics such as density, mode 
of biogenesis, and molecular markers such as CD63, 
CD81 and AnnexinV are used to classify EVs [44].
Recently, EVs have emerged as interesting research 
investigations in both the early detection of malignant 
tumors and signaling cascade between cells [18]. EVs, 
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due to their natural ability to transfer biomacromolecules, 
have also been used as safe vehicles for the delivery 
of targeted drugs, as well as miRNAs, siRNAs, and 
miRNA inhibitors [7, 46]. Role of EVs was underlined 
in various level of the immune escape, drug resistance, 
formation of premetastatic niche and angiogenesis of 
tumors [46–48]. However, little is known about the role 
of EVs in cellular crosstalk in head and neck cancer and 
their possible mechanistic roles. It has been shown that 
a great proportion of miRNAs was associated with EVs 
and therefore are remarkably stable, and protected from 
endogenous RNase activity [18, 44, 49]. 
In this study, we showed that EVs are increased in 
the circulation of patients with OSCC and those EVs carry 
a set of oncogenic miRNAs. We isolated and characterized 
the EVs derived from OSCC cells and demonstrated that 
these are transferable to monocytes. We also characterized 
the miRNA cargo of OSCC-derived EVs and parental cells 
in the unstimulated state and stimulated with alcohol, a 
known OSCC risk factor. A set of miRNA was enriched 
explicitly in EVs, and functional network analysis showed 
that the novel EV associated miRNA signature of miR-
22-3p, miR-130a-3p, miR-20a-5p, miR-21-5p, miR-195-
5p, miR27a-3p, miR-19a-3p regulates different cancer- 
and innate immunity associated pathways. miR-21 was 
among the highly expressed miRNAs in both circulations 
of patients with OSCC and OSCC cells, therefore we 
determined the biological role of this miRNA in current 
study. Moreover, the level of miR-21 was increased in the 
EVs isolated from OSCC cells that were challenged with 
alcohol. We showed that EVs derived from cancer cells 
could be taken up by monocyte/macrophages and activate 
the NF-κB pathway through horizontal transfer of miR-21.
Endogenous RNAs acting as damage-associated 
molecular patterns (DAMPs) for pattern recognition 
receptors (PRRs) and may induce such signals [50]. 
Although these RNAs must remain unrecognized under 
non-pathological conditions, unshielded RNA packaged 
into the EVs is capable of inducing inflammatory responses 
in cancer cells [50]. Consistent with this concept we 
Figure 5: Uptake and biological activity OSCC derived EVs in human THP1 monocytes. (A–D) Levels of miR-21 and 
IL-6 protein, MCP1 protein and IL-1β protein levels were quantified by a TaqMan Assay (miR-21) and ELISA assays respectively in 
EVs derived from CAL27. The quantitative results represent three independent experiments. (E, F) Levels of miR-21 and IL-6 protein 
were quantified by a TaqMan Assay and ELISA assays respectively, in EVs derived from THP1 cells. (G) EVs derived from CAL27 cells 
were labeled with green fluorescent dye (PKH67) and co-cultured with THP1 cells (2 h). DAPI was used to stain the nuclei. Nomarski 
Interference Contrast (NIC) was used for identifying the cytoplasm. EVs were taken up by the THP1 cells evidenced by the presence of 
green fluorescently labeled exosomes in the cytoplasm of the THP1 monocytes in the merged image. (H–J) Levels of miR-21 and pri-
miR-21 were quantified by a TaqMan miRNA Assay and TaqMan Pri-miRNA Assay respectively at the indicated time points. (K) Level 
of miR-21 uptake was determined by qPCR after EV uptake in cells treated with varying concentrations of Cytochalasin D (CYTO D). 
(L) EVs were isolated from CAL27 cells from three independent experiments and were cocultured with human THP1 monocytes for 
6 h. THP1 cells were treated or not with 10 ng/ml LPS for 6 h, and 10 μg of whole cell lysate were subjected to EMSA to evaluate NF-κB 
activation. (*indicates p < 0.05 versus control).
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showed that EVs and EV-associated miR-21 could activate 
NF-κB pathway and induce inflammation in monocytes. 
Activation of NF-κB is part of the immune defense, which 
targets and eliminates transformed cells. This seems to be 
particularly true for acute inflammatory processes, where 
full activation of NF-κB is accompanied by high activity of 
cytotoxic immune cells against cancer cells. This immune 
defense against cancer cells, however, is normally not 
tight enough to eliminate all the aberrant cells, resulting 
in a shift to an equilibrium phase, which is often followed 
by an “escape” phase of the cancer cells, in which they 
outperform the immune system [51].
In this study, we found the horizontal transfer of 
miR-21 from OSCC cells to human monocytes. The 
de novo increased expression of miR-21 has been ruled 
out since levels of pri-miRNA-21 were unchanged in 
the cells challenged with EVs compared to the controls. 
However, in the later time points (18 h) we observed a 
significant increase in the pri-miRNA-21 expression 
indicating the downstream de novo expression of this 
miRNA after induction of NF-κB activation by tumor-
derived EVs. Consistent with our findings other studies 
also reported the de novo expression of miR-21 as a 
downstream of NF-κB activation in cells with monocytic 
lineage [52]. In another report, miR-21 mimics induced 
more than a 2-fold induction of pro-tumorigenic IL-6 
mRNA levels in THP1 cells compared with the control 
mimic [53], which is consistence with the effect of 
miR-21 that we observed in THP1 monocytes. Our data 
suggest that EVs horizontally transfer miR-21 and further 
activate surrounding immune cells to produce more pro-
tumorigenic cytokines.
The inflammatory response and NF-κB activation 
have been reported to be associated with the formation 
of the pre-metastatic niche and cancer progression 
[54]. Specifically, activation of NF-κB usually leads to 
overexpression of anti-apoptotic genes thereby promoting 
cell survival mechanism to survive the cellular stress that 
propagated by the inflammatory response. Role of NF-κB 
pathway has been signified in controlling epithelial 
to mesenchymal transition as well as metastasis [55]. 
Additionally, NF-κB activation produces cytokines that 
regulate the immune response (such as IL-6, TNFα, and 
IL-8), which orchestrates the presence of leukocytes to 
the sites of inflammation [54, 56]. The mechanistic role 
of NF-κB in promoting metastasis involves up-regulation 
of matrix metalloproteinases (MMPs) which provide the 
escape environment for tumor evasion [57]. In the present 
research, we demonstrated that EVs derived from cancer 
cells could be taken up by monocytes and activate NF-κB 
Figure 6: Immunomodulatory effects of EVs derived from OSCC cells (CAL27) on human THP1 monocytes. (A) 
MCP1 mRNA level was determined by qPCR after 12 h co-culture of OSCC EVs with THP1 monocytes. (B, C) MCP1 protein levels 
were determined by ELISA 24 h and 48 h after coculture with EVs derived from OSCC cells. (D) MMP-9 protein levels were identified 
in the supernatant of THP1 cells 24 h after challenge with OSCC EVs. (E) mRNA levels of COX2 was quantified by qPCR. (F) VEGF 
mRNA level was measured by qPCR (G). mRNA level of PGE2 was quantified by qPCR. For real time PCR, 18s was used as endogenous 
normalizer. (H) Protein levels of PEG2 was determined by ELISA. (I, J) Protein levels of IL-6 were quantified in the supernatant of THP1 
cells by ELISA in different conditions. (*indicates p < 0.05 versus control; **indicates p < 0.05 between marked groups). 
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in the recipient cells. The activation of NF-κB increased the 
pro-inflammatory cytokines such as IL-6, PGE2, and MCP1. 
Monocytes are critical for the formation of tumor 
microenvironment and the initiation of tumor angiogenesis 
because they adhere to and invade endothelium activated 
by the increased shear stress that results from large 
pressure differences between perfused areas. MCP1 is 
one of the pivotal chemokines that regulate migration 
and infiltration of monocyte/macrophages and has been 
suggested as one of the major players of monocyte 
migration in the tumor microenvironment. The secretion 
of MCP1 by tumor-infiltrating immune cells, malignant 
cells, and other stromal cells suggests that MCP1 mainly 
supports tumor progression MCP1 attracts monocytes and 
also promote macrophage infiltration and macrophage-
mediated angiogenesis [58, 59]. Expression of both 
MCP1 and VEGF have been positively associated with 
the presence of more tumor-associated macrophages 
and angiogenesis [60]. Consistently, we found increased 
levels of VEGF and MCP1 expression in monocytes after 
co-culture with tumor-derived EVs. We also found an 
increased production of PGE2 in human THP1 monocytes 
after co-culture with EVs. PGE2 is generally considered 
to possess strong pro-tumorogenic activity [61]. In a 
gain of function experiment, we delivered miR-21 in the 
comparable amount found in the circulation of patients 
with OSCC into the THP1 cells and found a comparable 
pro-inflammatory response in the monocytes. In the loss 
of function experimental setting, the introduction of 
miR-21 inhibitor to the THP1 cells attenuated the pro-
inflammatory profile seen after challenge with OSCC-
derived EVs. These results indicated that EV-medicated 
pro-inflammatory profiling of THP1 cells could at least 
partially be explained by the horizontal transfer of miR-
21 via EVs. 
In the present study, we showed that oncomiR 
such as miR-21 and miR-27 family are present with high 
abundance in the circulation of patients with oral cancer. 
EVs isolated from the circulation of OSCC patients and 
an OSCC cell line showed comparable miRNA profile, 
indicating the tumor origin of EVs in the circulation 
of patients with OSCC. In a series of experiments, 
we showed that EVs were taken up shortly by human 
monocytes after co-culture. Uptake of EVs derived 
from OSCC cells by monocytes caused activation of the 
inflammatory pathways, specifically NF-κB activation, and 
Figure 7: Gain- and loss- of function of miR-21 reveals its mechanistic role in the induction of pro-inflammatory 
phenotype in monocytes. (A) miR-21 (at concentration of 150 pmol) or control mimic were electroporated into the human THP1 
monocytes. THP1 cells were treated or not with 10 ng/ml LPS for 6 h, and 10 μg of whole cell lysate were subjected to EMSA to evaluate 
NF-κB activation. (B) Level of IL-6 was quantified by ELISA in the supernatant of THP1 cells 24 h after the introduction of miR-21 
mimic. (C) Level of PGE2 was quantified by ELISA in the supernatant of THP1 cells 24 h after the introduction of miR-21 mimic. (D) 
COX2 mRNA was quantified using qPCR from cells 24 h after the introduction of miR-21 mimic. (E) miR-21 inhibitor (at concentration 
of 200 pmol) or control inhibitor were electroporated into the human THP1 monocytes and efficacy of inhibition was measured at 24 h. (F) 
IL-6 protein levels were quantified by ELISA in the supernatant of THP1 cells 72 h after the introduction of miR-21 inhibitor. (G) Level 
of PEG2 was quantified by qPCR in the THP1 cells 48 h after the introduction of miR-21 inhibitor. (*indicates p < 0.05 versus control; 
**indicates p < 0.05 between marked groups).
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EVs conferred pro-tumorigenic properties and activated 
pro-tumor effectors in the recipient monocytes. These 
findings have possible implications for developing OSCC 
biomarkers and understanding and targeting the molecular 
and vesicular effectors in the tumor microenvironment.
MATERIALS AND METHODS
Cell culture and EV isolation
CAL27 cells were purchased from ATCC and were 
cultured in Dulbecco’s modified medium (DMEM) plus 
10% exosome-depleted FBS (Exo-FBS™) (Mountain 
View, CA, USA), and 1% penicillin/streptomycin (Gibco®, 
NY, USA). THP1 monocytes were cultured in RPMI 
media containing 10% exosome depleted FBS and 1% 
penicillin/streptomycin at 37° C in a 5% CO2 atmosphere. 
For evaluation of effects of ethanol administration, 
25 mM, 50 mM, and 100 mM of ethanol were added to 
the cells for various time points (24 h, 48 h, and 72 h). 
At desired time points, conditioned media was collected, 
and EVs were isolated or quantified using a Nanoparticle 
Tracking Analysis (NTA) system as described 
previously [62].
For EV isolation from CAL27 cells, supernatants 
were centrifuged at 1500 g for 8 minutes to remove cells. 
Afterward, centrifugation at 10000 g for 20 minutes was 
done to deplete residual cellular debris. The supernatant 
was used to isolate EVs based on a polymer precipitation 
method with ExoQuick-TC™ (System Biosciences, USA). 
The manufacturer guidelines were used to isolate EVs. EVs 
were re-suspended in PBS for further analysis or functional 
experiments. For co-culture experiments, EVs isolated from 
OSCC cell line (CAL27) were added to THP1 cells for 2 h 
in the concentration of 85 μg/ml. This concentration was 
comparable to EVs concentration in the human circulation 
of human subjects with OSCC. After 2 h of co-culture 
of EVs with THP1 cells, THP1 cells were sedimented 
by centrifugation at 1000 RPM. 1000 RPM is capable of 
sedimenting cells, based on the density of EVs they are 
unlikely to co-participate with the THP1 cells. In fact, our 
quality control analysis showed EVs to be in the supernatant 
fraction. For ruling out any possible co-precipitation of EVs 
with cell pellet, cells were washed two times with PBS, 
centrifuged and harvested. 10 nM LPS was added 6 h before 
the readouts in the group, which involved LPS challenge.
Isolation of EVs from plasma
For EV isolation from the plasma of human subjects 
(n = 34), EVs were isolated from 100 μl of plasma with 
ExoQuick reagent (System Biosciences, USA) according 
to the recommended protocol by the manufacturer. 
Patient samples were obtained from the University of 
Massachusetts Medical School Conquering Diseases 
Biorepository that were collected based on an institutional 
review board guidelines.  
Electrophoretic mobility shift assay (EMSA)
NF-κB activation in THP1 monocytes was evaluated 
after 6 h co-culture of EVs or 10 ng/ml LPS with the 
cells. Whole cell lysate was isolated, and 10μg of protein 
from THP1 monocytes was labeled with NF-κB probe 
consensus ds NF-κB oligonucleotide (5′-AGTTGAG 
GGGACTTTCGC-3′) End labeling was performed using 
T4 polynucleotide kinase in the presence of [γ-32P] ATP 
(Perkin Elmer, USA). Labeled oligonucleotides were 
purified with polyacrylamide copolymer column (Bio-Rad, 
USA). 10 μg from each sample was added to a reaction 
mixture containing 20 mM HEPES (pH 7.9), 50 mM 
KCl, 0.1 mM EDTA, 1 mM DTT, 5% glycerol, 200 μg/ml 
BSA, 2 μg of polydeoxyinosinic-polydeoxycytidylic acid, 
and γ-32P-labeled NF-κB oligonucleotide and incubated 
at room temperature for 30 mins. All reactions were run 
on a 6% polyacrylamide gel, and dried gel was exposed 
to X-ray film and kept at –80° C. For cold competition 
control, a 20-fold excess of the specific unlabeled double-
stranded probe was added to the reaction mixture before 
adding the labeled oligonucleotide. 
Characterization of EVs
EVs were characterized by Nanoparticle Tracking 
Analysis (NTA), scanning electron microscopy 
(TEM), and Western blot regarding concentration, size, 
morphology, and surface marker respectively.
Nanoparticle tracking analysis (NTA)
The concentration and diameter of EVs derived 
from plasma of human subjects and culture supernatant 
were identified by a NanoSight NS300 system (NanoSight, 
Amesbury, UK) equipped with fast video capture and 
Nanoparticle Tracking Analysis (NTA) software. Before 
each measurement, the instrument was calibrated with 
100 nm polystyrene beads (Thermo Scientific, California, 
USA) as recommended by the manufacturer. The samples 
were recorded for 90s at controlled room temperature. 
NTA software was utilized to quantify the concentration 
of the particles (particles/ml) and size distribution (in 
nanometer). Measurements were done in triplicates. 
Western blotting
After isolation of EVs, the presence of EV 
markers, CD63 was assessed with western blot. Briefly, 
RIPA buffer was (Thermo scientific, USA) added to the 
EVs; EV proteins were extracted and run on 10% SDS-
PAGE gels. Proteins were transferred to nitrocellulose 
membrane and were blocked for 1 h in TBS containing 
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5% non-fat dry milk and 0.1% Tween-20. The blots were 
incubated overnight with primary CD63 antibody (Abcam, 
Cambridge, USA) at 4° C. The blots were washed 3 times 
with TBST and then incubated for 1 hour with horseradish 
peroxidase-conjugated secondary goat anti-mouse IgG-
HRP antibody (Abcam, Cambridge, USA) (dilution 
1:10,000). Chemiluminescent Protein bands were detected 
using a Clarity™ Western ECL substrate kit (BioRad, 
USA) with an exposure time of 30s and analyzed with a 
Fujifilm LAS-4000 luminescent image analyzer.
Confocal microscopy
EVs were collected from the supernatant of CAL 
27 cells and were labeled with PKH67 green fluorescent 
cell linker kit (Sigma-Aldrich, USA). Co-culture of EVs 
with THP1 cells was done for 2 h, and then cells were 
washed out thoroughly with PBS 3 times to remove EVs. 
After 2 h, an uptake of labeled exosomes by recipient 
THP1 cells were visualized by a Leica TCS SP5 II laser 
scanning confocal microscope equipped with a 63X phase 
objective. Nomarski interference microscope was used to 
contrast the plasma membrane and nuclei were stained 
with DAPI (blue). Confocal stacked images (0.2 μm stack 
step, 1 μm range) were acquired and the Leica Application 
Suite (LAS) which integrates Leica automated microscopes 
images was used to construct 3D projections of image 
stacks.
RNA isolation and small RNA profile
Both cells and exosomes were lysed in QIAzol Lysis 
reagent (Qiagen, Maryland, USA) and total RNA was 
isolated using miRNAeasy kit (Qiagen, Maryland, USA.) 
100 μL of EVs suspension from plasma of patients, control 
subjects and, from supernatant of ethanol-treated cells, 
or normal cells were mixed with 400 μL QIAzol lysis 
buffer, and the mixture was processed according to the 
standard recommended protocol to extract the RNA. RNA 
was eluted with 30 μL of RNase-free water. The quantity 
and quality of the RNA were determined by NanoDrop 
1000 (260/280 and 260/230 ratios) for cells. Aliquots of 
~10 ng were submitted to capillary electrophoresis on a 
Bioanalyzer small RNA chip (Agilent). RNase protection 
assay was performed as previously described to confirm 
the intraluminal topology of EV associated extracellular 
RNA (25).
Quantitative polymerase chain reaction (qPCR)
First, cDNA was transcribed from 500 ng of total 
RNA utilizing iScript™ cDNA synthesis kit (Bio-Rad) 
in a final volume of 20 μl. SYBR-Green-based real-
time quantitative PCR (qPCR) was performed using the 
AB7300 Thermocycler, and the Bio-Rad CFX96 Real-
time PCR Detection system was used for qPCR. The 
primer sequences were as follows: human GAPDH, 
forward, 5′-AGGGCTGCTTTTAACTCTGGT-3′; and 
reverse, 5′-CCCCACTTGATTTTGGAGGGA-3′; 18 S, 
forward, 5′-GACCTCATCCCA CCTCTCAG-3′, and 
reverse, 5′-CCATCCAATCGGTAGTAGCG-3′; human 
VEGF, forward, 5′-TTCATGGATGTCTATCAGCG-3′, 
and reverse, 5′-CATCTCTCCTATGTGCTGGC-3′; human 
MCP1, forward, 5′- CCCCAGTCACCTGCTGTT AT 
-3′, and reverse, 5′- TGGAATCCTGAACCCACTTC-3′; 
human COX2, forward, 5′- CCTTCCTCCTGTGCCT 
GATG-3′, and reverse, 5′-ACAATCTCATTTGAAT 
CAGGAAGCT3′; human PTGES2, forward, 5′- CTT 
CCTTTTCCTGGGCTTCG-3′, and reverse, 5′- GAAGAC 
CAGGAAGTGCATCCA-3′. 18s or GAPDH were used as 
an endogenous normalizer, and relative expression levels 
were calculated using the ΔΔCt method. 
TaqMan MicroRNA assays
TaqMan® miRNA Assays (Applied Biosystems, 
Foster City, USA) was utilized for quantification of miR-
21, miR-27a, miR-155, miR-27b expression according to 
the manufacturer’s protocol. Reverse transcription step 
was as the following: 30 min, 16° C; 30 min, 42° C; and 
5 min 85° C. miRNA reverse transcription was done with 
the mixture of TaqMan stem-loop primer, 10 ng RNA, 
TaqMan primers and kit according to the manufacturer’s 
recommendation. qPCR was using TaqMan Universal 
PCR Master Mix and recommended protocol by the 
manufacturer. RNU48 was used to normalize the Ct values 
between the samples. In experiments involving miRNA 
analysis of EVs and patients’ plasma, the same volume 
of starting material was used and synthetic C. elegans 
(cel)-miR-39 was spiked during the total RNA isolation 
process and used to normalize the qPCR data. TaqMan® 
Pri-miRNA for miR-21 Assay was performed using FAM 
dye-labeled TaqMan with GAPDH as an internal control. 
Experiments were done in triplicate. Levels of miRNAs 
were normalized, and the relative expression levels of 
each miRNA were presented and analyzed by 2–ΔΔCt as 
described by Livac and Schmittgen (26).
Transfections via electroporation 
For the direct introduction of miR-21 mimic 
(150 pmol) or miR-21 inhibitor (200 pmol) (Ambion, 
USA), THP1 cells were transfected by electroporation 
as follows using our previously established method (7). 
Briefly, 2 × 105 cells were re-suspended in 150 μl complete 
RPMI media and 150 μl Gene Pulser® electroporation 
buffer for 10 min on ice before being electroporated. 
Electroporation was done at 300 kV and 1500 μF. 
Following electroporation, cells were kept on ice for 10 min 
then cultured in media for 24 hrs. Similar concentrations of 
miR control mimics and negative inhibitor were introduced 
to the THP1 cells using similar approach and conditions.
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Enzyme-linked immunosorbent assay (ELISA)
Levels of TNFα (R&D Systems, Minneapolis), 
MCP1 (BioLegend, San Diego), prostaglandin E2 
(PGE2) ELISA Kit (Abcam, Cambridge), IL-6 (R&D 
Systems, Minneapolis), MMP9 (Abcam) and IL-1β (R&D 
Systems, Inc., Minneapolis) were measured from cell free 
supernatants following manufacturer’s recommendations 
after construction of standard curve and measured using 
an ELISA reader. Results were expressed as mean ± SD. 
The statistical significance was determined between two 
groups with the student’s t-test after one-way analysis of 
variance.
Microarray analysis and pathway enrichment 
analysis
The Firefly miRNA multiplex assay (Firefly™ 
bioworks, Cambridge, USA) was used to profile EV-
associated miRNA isolated from CAL27 cells and cells in 
different conditions (non-challenged and challenged with 
25 mM ethanol) for a targeted list of 68 miRNAs in the 
oncogenic panel. Total RNA (12 μl) was used to run the 
Firefly standard protocol and the abundance of RNA probes 
analyzed with a Millipore Guava 8HT flow cytometer 
(EMD Millipore). Analysis and visualization of data 
were performed using a Firefly™ Analysis Workbench. 
Intensities were transformed to log ratio for each probe. 
Negative control values for each probe was subtracted 
from each sample and normalization was done based on 
the geometric mean of most stable reference genes based 
on the software built in the algorithm. Signal log ratios 
were computed by using a t-test and false discovery rate 
was controlled at 5% using the Benjamini-Hochberg 
procedure. The identified miRNAs were clustered in by 
K mean clustering method and heat-map was constructed. 
The miRNAs that were specifically enriched in EVs were 
subjects to functional network analysis through miRNet 
which combine the target interaction data from 11 well-
annotated miRNA datasets including PhenomiR, SM2miR, 
TarBase, HMDD, PharmacomiR and miR2Disease (27). 
Network visualization and functional enrichment analysis 
were performed based on Reactome, Gene Ontology, and 
KEGG to identify dysregulated pathways associated with 
enriched miRNAs in EVs by a hypergeometric test as well 
as small molecules interactions (27). 
Statistical analysis
After determination of data distribution, one-
way analyses of variance (ANOVA) or Kruskal-Wallis 
nonparametric test were used to compare different groups. 
Student’s t-test or Mann–Whitney U test was for pair-
wise group comparisons. Data are presented as a mean ± 
standard error of the mean (SEM) or standard deviation 
(SD) and P values of less than 0.05 were identified as 
statistically significant.
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